by John McMillan | Jun 27, 2025 | COVID-19, Ethics
Dr. Philp McMillan, John McMillan In the late 1950s, doctors prescribed a new drug to pregnant women suffering from morning sickness. Thalidomide was marketed as completely safe, a breakthrough in prenatal care. Women trusted their physicians and the pharmaceutical...
by John McMillan | Jun 20, 2025 | COVID-19, Ethics
Dr. Philp McMillan, John McMillan On January 9th, 2025, something unprecedented happened in American public health: all 17 members of the Advisory Committee for Immunization Practices (ACIP) were fired. Robert F. Kennedy Jr., the newly appointed Secretary of Health...
by John McMillan | Jun 13, 2025 | COVID-19, Ethics
Dr. Philp McMillan, John McMillan Virologist Geert Vanden Bossche recently launched a fierce rebuttal against FDA Commissioner Dr. Marty Makary; something far more significant than a scientific disagreement. This was the spectacular collapse of any remaining...
by John McMillan | Jun 6, 2025 | COVID-19, Health
Dr. Philp McMillan, John McMillan At 38, Novak Djokovic is on the verge of his 25th Grand Slam title, powering into the quarterfinals of the 2025 French Open. Meanwhile, Roger Federer retired at 41 after multiple knee surgeries, Rafael Nadal stepped away at 38 due to...
by John McMillan | May 30, 2025 | COVID-19, Health
Dr. Philp McMillan, John McMillan “”What if we studied success stories as intently as we study vaccines?” 837 is a number that should have stopped the world’s epidemiologists in their tracks. That’s the total COVID-19 death toll Haiti...
by John McMillan | May 23, 2025 | COVID-19, Health, Policy
Libby Richards, Purdue University On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine. The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for...
Recent Comments